The global anticoagulant market is currently undergoing a massive transformation, driven by an aging population and the increasing prevalence of cardiovascular diseases (CVDs). As a top-tier manufacturer and supplier landscape, China has emerged as the critical backbone for Active Pharmaceutical Ingredients (APIs) and chemical intermediates that power the world's blood-thinning medications.
Hangzhou Jeci Biochem Technology Co., Ltd. stands at the intersection of innovation and industrial scale. With deep-rooted partnerships with new drug research institutes and GMP-certified manufacturing facilities, we provide more than just products—we provide verified "Information Gain" through technical dossiers, regulatory support, and supply chain transparency. Our presence in Hangzhou, a hub for high-tech biotech, allows us to leverage top-tier talent and logistics infrastructure.
Focusing on Low Molecular Weight Heparin (LMWH) and Unfractionated Heparin (UFH). China remains the primary source for crude heparin, where stringent purification processes ensure high efficacy and safety.
Novel Oral Anticoagulants (NOACs) like Rivaroxaban and Apixaban have revolutionized treatment. We specialize in the advanced intermediates required for these complex Factor Xa inhibitors, ensuring high purity levels.
The next frontier involves personalized dosage forms and genetic-response-based formulations. Our R&D teams are exploring the customization of APIs to meet localized healthcare demands across Southeast Asia and Europe.
Anticoagulants are not limited to hospital pharmacies. Their application spans multiple sectors:
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Drugs and intermediates are widely used in pharmaceutical intermediates, industrial raw materials, and essential substances for advanced intermediates.
We assemble and produce larger quantities of intermediates with advanced, convenient manufacturing capabilities, including batch processing and customization.
SJ medical
